Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: interesting presentation

I'm puzzled how a report written on February 7th states that the '336 was invalidated by Pubpat? The patent was under review but certainly not invalidated at that point, and technically still isn't.

Share
New Message
Please login to post a reply